Skip to content

After the earthquake, the National Immunization Program (DPEV, from the French acronym), with support from the Pan American Health Organization/World Health Organization and UNICEF, developed a National Post-Disaster Vaccination Plan. The main objective of this plan was to minimize the occurrence of vaccine-preventable diseases in the aftermath of the earthquake. This plan included immediate provision of Td/TT vaccine and tetanus anti-toxin to persons injured during the earthquake and those undergoing emergency surgeries, including amputations. It also included vaccination against diphtheria, tetanus (and whooping cough for children), measles and rubella, the provision of vitamin A supplements and albendazole, as follows:

  • Children aged 6 weeks to 8 months – DTP
  • Children aged 9 months to 7 years – DTP, MR and vitamin A supplements
  • Persons aged 8 years and more – Td
  • All children aged >=2 years – Albendazole

The post-disaster vaccination plan also includes intensification of routine vaccination with all the EPI vaccines, as an integrated health package, for children aged <5 years, and epidemiological surveillance in health institutions and at community level.

Phase 1.

  • Vaccination of displaced population living in temporary settlements in disaster affected communes (second administrative level or district equivalent).
    • These include Port-au-Prince, Petion Ville, Delmas (including Tabarre and Cite Soleil), and Carrefour in the Metropolitan Area; Croix de Bouquet, Leogane, Gressier, Grand Goave and Petit Goave in the Ouest Department and Jacmel in the Sudest Department.
  • Even though vaccines are offered to the entire population in the camps, children have been the main focus.
  • The target population was initially estimated at around 1.4 million people (around 250,000 children aged 6 weeks to 7 years) living in over 300 sites, using data from the Office for the Coordination of Humanitarian Affairs of the United Nations (OCHA).
    • These estimates are changing as responsible for immunization are conducting pre-vaccination site visits
    • The observed tendency was towards overestimation of the population
  • The estimates by age group, were done applying the age distribution in the general population (1.86% for 6 weeks-8 months; 15.71% 9 months -7 yrs; and 82.43% 8yrs +).
  • One of the biggest challenges has been determining the target population, mainly due to:
    • Transient nature of some of the population
    • The behavior of the persons living in the sites (adults go out during the day)
    • The disappearance of originally identified sites and appearance of spontaneous new sites in several localities
    • The multiple names given to the sites, leading to some double counting
  • Rapid coverage monitoring is being implemented following vaccination in the sites to provide the basis to do mop-up activities.
    • The mop-up activities are targeting the sites with the largest numbers of unvaccinated persons.
  • High-demand for vaccination has been observed and no delays attributable to targeting both children and adults have been identified.
  • Events supposedly attributable to vaccination or immunization (ESAVI), mostly local reactions and fever, have been noted by the population and health personnel working on the sites.
  • This phase is ongoing and expected to be finished by mid-April. Jacmel has not started vaccination.
    • Jacmel is due to start 5 April.

The table below shows progress as of 30 March 2010. Data entry is ongoing.

Phase 2. This phase aims to provide the same package of interventions to all people living in the affected areas, thus, providing a second dose of DTP/Td and MR for previously vaccinated persons and an additional opportunity for those not living in tents or missed in phase 1. No date has been set, but it is planned for when the situation stabilizes. In addition, a simultaneous follow-up campaign with MR and OPV for the rest of the country is being considered.

Phase 3. Re-launching of the routine immunization program, including fixed posts and “advanced strategy” of periodic vaccination intensification in areas where the population congregates. This phase is being started during Vaccination Week in the Americas 2010 in the Departments of the south, bordering with the Dominican Republic. This phase contemplates also the launching of the revised National Immunization Plan of Action 2010-2013; the roadmap for routine vaccination and the introduction of the DTP-HepB-Hib (pentavalent) vaccine.

Last Updated on Friday, 09 April 2010 12:16

Regional Office for the Americas of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

© Pan American Health Organization. All rights reserved.